The latest cancer news for cancer research. Inform yourselves about the newest technologies, best practices and studies in the field of cancer diseases and tumors.

• Streamlined process opens drug development to a new class of steroids September 25, 2017
  Researchers have developed a technique to produce synthetic steroids that could pave the way for a cascade of new drug discoveries, significantly reducing the expense and time needed to develop therapeutics from an underexplored collection of molecules.
• Adding radiation to chemotherapy may dramatically improve survival for advanced NSCLC September 25, 2017
  Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomized phase II clinical trial.
• Genes are controlled by 'Nano footballs,' scientists discover September 25, 2017
  Genes are controlled by 'nano footballs' -- structures that look like footballs but 10 million times smaller than the average ball -- new research has revealed.
• Newly revealed autism-related genes include genes involved in cancer September 25, 2017
  Researchers have applied a computational technique that accounts for how genes interact, to find new networks of related genes that may be involved in autism spectrum disorder. Some of the genes have not been previously linked to the disorder, and could help scientists to better understand it and develop new treatments.
• Up to one-quarter of cancer patients use marijuana September 25, 2017
  A new study conducted in a cancer center in a state with legalized medicinal and recreational marijuana found that approximately one-quarter of surveyed patients used marijuana in the past year, mostly for physical and psychological symptoms.
• MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer September 25, 2017
  A new magnetic resonance imaging contrast agent being tested by researchers not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing types.
• New genetic syndrome predisposes the body to cancer September 22, 2017
  A new syndrome caused by biallelic mutations -- those produced in both gene copies inherited from the mother and father -- in the FANCM gene predisposes the body to the appearance of tumors and causes rejection to chemotherapy treatments. Contrary to what scientists believed, the gene does not cause Fanconi anemia. Researchers recommend modifying the clinica […]